Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201107040 Principal Investigator: Linette, Gerald
Title: A Phase II Study of Sunitinib (SUTENT) in Patients with Metastatic Mucosal or Acral/Lentiginous Melanoma
Phase: II Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to evaluate how effective an investigational drug called SUTENT® works in treating acral lentigenous and mucosal melanoma which has spread beyond the local region.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)